Skip to Main Content

Advertisement intended for health care professionals

American Society of Hematology Logo
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 109, Issue 5
March 1 2007
Blood Cover Image for Volume 109, Issue 5

Table of Contents

INSIDE BLOOD

HEMOSTASIS
Full clot retraction: running on mTOR
Michael C. Berndt,Robert K. Andrews
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
CHEMOKINES
HTLV-IIb reduces HIV infection
Davide Zella
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
HEMOSTASIS
Thrombospondin says no to NO
Themis R. Kyriakides
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
CLINICAL TRIALS AND OBSERVATIONS
Acquired hemophilia A: is more better?
Clinical Trials & Observations
Joan Cox Gill
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
HEMOSTASIS
Bone morphogenetic proteins go endothelial
Danny Huylebroeck
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
HEMOSTASIS
Will the real EPC please stand up?
Aernout Luttun,Catherine M. Verfaillie
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
IMMUNOBIOLOGY
Fast track to becoming a regulatory T cell: “trogocytosis” of immune-tolerogenic HLA-G
Heinz Wiendl
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
NEOPLASIA
Advances in myeloma therapy: breaking the cycle
Carl Gregory
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

BLOOD WORK

Beyond the wide blue sea
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

PLENARY PAPERS

Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals
Mervin C. Yoder,Laura E. Mead,Daniel Prater,Theresa R. Krier,Karim N. Mroueh,Fang Li,Rachel Krasich,Constance J. Temm,Josef T. Prchal,David A. Ingram
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

PERSPECTIVE

End points to establish the efficacy of new agents in the treatment of acute leukemia
Clinical Trials & Observations
Frederick R. Appelbaum,Daniel Rosenblum,Robert J. Arceci,William L. Carroll,Philip P. Breitfeld,Stephen J. Forman,Richard A. Larson,Stephanie J. Lee,Sharon B. Murphy,Susan O'Brien,Jerald Radich,Nancy S. Scher,Franklin O. Smith,Richard M. Stone,Martin S. Tallman
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

ERRATUM

Correction for Dou et al., Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Correction for Kelly et al., CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen-specific memory B cells
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

REVIEW ARTICLES

Neutrophil elastase in cyclic and severe congenital neutropenia
Clinical Trials & Observations
Marshall S. Horwitz,Zhijun Duan,Brice Korkmaz,Hu-Hui Lee,Matthew E. Mealiffe,Stephen J. Salipante
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

CHEMOKINES, CYTOKINES, AND INTERLEUKINS

Endolyn (CD164) modulates the CXCL12-mediated migration of umbilical cord blood CD133+ cells
Sinead Forde,Britt Jorgensen Tye,Sarah E. Newey,Maria Roubelakis,Jon Smythe,Colin P. McGuckin,Ruth Pettengell,Suzanne M. Watt
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor
Helena Stabile,Stefania Mitola,Emanuela Moroni,Mirella Belleri,Stefania Nicoli,Daniela Coltrini,Francesco Peri,Antonello Pessi,Laura Orsatti,Fabio Talamo,Vincent Castronovo,David Waltregny,Franco Cotelli,Domenico Ribatti,Marco Presta
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Noninfectious papilloma virus–like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27
J. Mohamad Fakruddin,Richard A. Lempicki,Robert J. Gorelick,Jun Yang,Joseph W. Adelsberger,Alfonso J. Garcia-Pineres,Ligia A. Pinto,H. Clifford Lane,Tomozumi Imamichi
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Postgenomic up-regulation of CCL3L1 expression in HTLV-2–infected persons curtails HIV-1 replication
Clinical Trials & Observations
Elisabetta Pilotti,Lisa Elviri,Elisa Vicenzi,Umberto Bertazzoni,Maria Carla Re,Sonia Allibardi,Guido Poli,Claudio Casoli
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

CLINICAL TRIALS AND OBSERVATIONS

The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
Clinical Trials & Observations
Laurie H. Sehn,Brian Berry,Mukesh Chhanabhai,Catherine Fitzgerald,Karamjit Gill,Paul Hoskins,Richard Klasa,Kerry J. Savage,Tamara Shenkier,Judy Sutherland,Randy D. Gascoyne,Joseph M. Connors
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Effect of genetic variations in platelet glycoproteins Ibα and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy
Clinical Trials & Observations
Paul F. Bray,Timothy D. Howard,Eric Vittinghoff,David C. Sane,David M. Herrington
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation
Clinical Trials & Observations
Peter W. Collins,Sybil Hirsch,Trevor P. Baglin,Gerard Dolan,John Hanley,Michael Makris,David M. Keeling,Ri Liesner,Simon A. Brown,Charles R. M. Hay,UK Haemophilia Centre Doctors' Organisation
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Late cardiotoxicity after treatment for Hodgkin lymphoma
Clinical Trials & Observations
Berthe M. P. Aleman,Alexandra W. van den Belt-Dusebout,Marie L. De Bruin,Mars B. van 't Veer,Margreet H. A. Baaijens,Jan Paul de Boer,Augustinus A. M. Hart,Willem J. Klokman,Marianne A. Kuenen,Gabey M. Ouwens,Harry Bartelink,Flora E. van Leeuwen
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

HEMATOPOIESIS

ATM deficiency disrupts Tcra locus integrity and the maturation of CD4+CD8+ thymocytes
Irina R. Matei,Rebecca A. Gladdy,Lauryl M. J. Nutter,Angelo Canty,Cynthia J. Guidos,Jayne S. Danska
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Retroviral vector insertion sites associated with dominant hematopoietic clones mark “stemness” pathways
Olga S. Kustikova,Hartmut Geiger,Zhixiong Li,Martijn H. Brugman,Stuart M. Chambers,Chad A. Shaw,Karin Pike-Overzet,Dick de Ridder,Frank J. T. Staal,Gottfried von Keudell,Kerstin Cornils,Kalpana Jekumar Nattamai,Ute Modlich,Gerard Wagemaker,Margaret A. Goodell,Boris Fehse,Christopher Baum
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
The paralogous hematopoietic regulators Lyl1 and Scl are coregulated by Ets and GATA factors, but Lyl1 cannot rescue the early Scl–/– phenotype
Wan Y. I. Chan,George A. Follows,Georges Lacaud,John E. Pimanda,Josette-Renee Landry,Sarah Kinston,Kathy Knezevic,Sandie Piltz,Ian J. Donaldson,Laure Gambardella,Fred Sablitzky,Anthony R. Green,Valerie Kouskoff,Berthold Göttgens
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Ape1 regulates hematopoietic differentiation of embryonic stem cells through its redox functional domain
Gang-Ming Zou,Mei-Hua Luo,April Reed,Mark R. Kelley,Mervin C. Yoder
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Mad2 is required for optimal hematopoiesis: Mad2 associates with c-Kit in MO7e cells
Shigeki Ito,Charlie R. Mantel,Myung-Kwan Han,Sunanda Basu,Seiji Fukuda,Scott Cooper,Hal E. Broxmeyer
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY

Active tissue factor pathway inhibitor is expressed on the surface of coated platelets
Susan A. Maroney,Sandra L. Haberichter,Paul Friese,Maureen L. Collins,Josephine P. Ferrel,George L. Dale,Alan E. Mast
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Tumor necrosis factor α (TNF-α) receptor-II is required for TNF-α–induced leukocyte-endothelial interaction in vivo
Unni M. Chandrasekharan,Maria Siemionow,Murat Unsal,Lin Yang,Earl Poptic,Justin Bohn,Kagan Ozer,Zhongmin Zhou,Philip H. Howe,Marc Penn,Paul E. DiCorleto
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide–mediated vascular smooth muscle relaxation
Jeff S. Isenberg,Fuminori Hyodo,Ken-Ichiro Matsumoto,Martin J. Romeo,Mones Abu-Asab,Maria Tsokos,Periannan Kuppusamy,David A. Wink,Murali C. Krishna,David D. Roberts
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells
Laurent David,Christine Mallet,Sabine Mazerbourg,Jean-Jacques Feige,Sabine Bailly
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Cooperation between VEGF and β3 integrin during cardiac vascular development
Sara M. Weis,Jeffrey N. Lindquist,Leo A. Barnes,Kimberly M. Lutu-Fuga,Jianhua Cui,Malcolm R. Wood,David A. Cheresh
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Human plasma fibrinogen is synthesized in the liver
Glenys A. Tennent,Stephen O. Brennan,Arie J. Stangou,John O'Grady,Philip N. Hawkins,Mark B. Pepys
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets
Andrew S. Weyrich,Melvin M. Denis,Hansjorg Schwertz,Neal D. Tolley,Jason Foulks,Eliott Spencer,Larry W. Kraiss,Kurt H. Albertine,Thomas M. McIntyre,Guy A. Zimmerman
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Acute inflammation is exacerbated in mice genetically predisposed to a severe protein C deficiency
Angelina J. Lay,Deborah Donahue,Meng-Ju Tsai,Francis J. Castellino
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivo
Toshihiko Nishimura,Timothy Myles,Adrian M. Piliposky,Peter N. Kao,Gerald J. Berry,Lawrence L. K. Leung
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men
Clinical Trials & Observations Brief Report
Chan K. N. K. Chion,Carine J. M. Doggen,James T. B. Crawley,David A. Lane,Frits R. Rosendaal
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

IMMUNOBIOLOGY

Differential epitope mapping of antibodies to PDC-E2 in patients with hematologic malignancies after allogeneic hematopoietic stem cell transplantation and primary biliary cirrhosis
Roberto Bellucci,Sabine Oertelt,Meagan Gallagher,Sigui Li,Emmanuel Zorn,Edie Weller,Fabrice Porcheray,Edwin P. Alyea,Robert J. Soiffer,Nikhil C. Munshi,M. Eric Gershwin,Jerome Ritz
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides
Hisaki Fujii,Jacqueline D. Trudeau,David T. Teachey,Jonathan D. Fish,Stephan A. Grupp,Kirk R. Schultz,Gregor S. D. Reid
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells
Natasha K. Crellin,Rosa V. Garcia,Megan K. Levings
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
IL-21 receptor signaling is integral to the development of Th2 effector responses in vivo
Anja Fröhlich,Benjamin J. Marsland,Ivo Sonderegger,Michael Kurrer,Martin R. Hodge,Nicola L. Harris,Manfred Kopf
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
ZAP-70 enhances B-cell–receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells
Stefania Gobessi,Luca Laurenti,Pablo G. Longo,Simona Sica,Giuseppe Leone,Dimitar G. Efremov
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells
Joel LeMaoult,Julien Caumartin,Marina Daouya,Benoit Favier,Solene Le Rond,Alvaro Gonzalez,Edgardo D. Carosella
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Cytotoxic CD4+ T cells use granulysin to kill Cryptococcus neoformans, and activation of this pathway is defective in HIV patients
Clinical Trials & Observations
Chun Fu Zheng,Ling Ling Ma,Gareth J. Jones,M. John Gill,Alan M. Krensky,Paul Kubes,Christopher H. Mody
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells
Marina I. Garín,Chung-Ching Chu,Dela Golshayan,Eva Cernuda-Morollón,Robin Wait,Robert I. Lechler
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Gene expression patterns in blood leukocytes discriminate patients with acute infections
Clinical Trials & Observations
Octavio Ramilo,Windy Allman,Wendy Chung,Asuncion Mejias,Monica Ardura,Casey Glaser,Knut M. Wittkowski,Bernard Piqueras,Jacques Banchereau,A. Karolina Palucka,Damien Chaussabel
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Expansion of Vδ1 T lymphocytes producing IL-4 in low-grade non-Hodgkin lymphomas expressing UL-16–binding proteins
Silvia Catellani,Alessandro Poggi,Andrea Bruzzone,Patrizia Dadati,Jean Louis Ravetti,Marco Gobbi,Maria Raffaella Zocchi
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7
Brief Report
Angela Malaspina,Susan Moir,Doreen G. Chaitt,Catherine A. Rehm,Shyam Kottilil,Judith Falloon,Anthony S. Fauci
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

NEOPLASIA

4q loss is potentially an important genetic event in MM tumorigenesis: identification of a tumor suppressor gene regulated by promoter methylation at 4q13.3, platelet factor 4
Suk Hang Cheng,Margaret H. L. Ng,Kin Mang Lau,Herman S. Y. Liu,Joyce C. W. Chan,Angela B. Y. Hui,Kwok Wai Lo,Hua Jiang,Jian Hou,Raymond W. Chu,Wai Shan Wong,Natalie P. H. Chan,,Ho Keung Ng
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Circulating proteasome levels are an independent prognostic factor for survival in multiple myeloma
Clinical Trials & Observations
Christian Jakob,Karl Egerer,Peter Liebisch,Seval Türkmen,Ivana Zavrski,Ulrike Kuckelkorn,Ulrike Heider,Martin Kaiser,Claudia Fleissner,Jan Sterz,Lorenz Kleeberg,Eugen Feist,Gerd-R. Burmester,Peter-M. Kloetzel,Orhan Sezer
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Antibody-based inhibition of DKK1 suppresses tumor-induced bone resorption and multiple myeloma growth in vivo
Shmuel Yaccoby,Wen Ling,Fenghuang Zhan,Ronald Walker,Bart Barlogie,John D. Shaughnessy, Jr
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias
Ellen Weisberg,Laurie Catley,Renee D. Wright,Daisy Moreno,Lolita Banerji,Arghya Ray,Paul W. Manley,Juergen Mestan,Doriano Fabbro,Jingrui Jiang,Elizabeth Hall-Meyers,Linda Callahan,Jamie L. DellaGatta,Andrew L. Kung,James D. Griffin
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
MEK blockade converts AML differentiating response to retinoids into extensive apoptosis
Michele Milella,Marina Konopleva,Cristina M. Precupanu,Yoko Tabe,Maria Rosaria Ricciardi,Chiara Gregorj,Steven J. Collins,Bing Z. Carter,Carmen D'Angelo,Maria Teresa Petrucci,Robin Foà,Francesco Cognetti,Agostino Tafuri,Michael Andreeff
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-κB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth
Rentian Feng,Gülsüm Anderson,Guozhi Xiao,Gary Elliott,Lorenzo Leoni,Markus Y. Mapara,G. David Roodman,Suzanne Lentzsch
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Enhanced natural-killer cell and erythropoietic activities in VEGF-A–overexpressing mice delay F-MuLV–induced erythroleukemia
David Cervi,Yuval Shaked,Mehran Haeri,Tatiana Usenko,Christina R. Lee,Jody J. Haigh,Andras Nagy,Robert S. Kerbel,Eitan Yefenof,Yaacov Ben-David
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Adaptive secretion of granulocyte-macrophage colony-stimulating factor (GM-CSF) mediates imatinib and nilotinib resistance in BCR/ABL+ progenitors via JAK-2/STAT-5 pathway activation
Ying Wang,Dali Cai,Cornelia Brendel,Christine Barett,Philipp Erben,Paul W. Manley,Andreas Hochhaus,Andreas Neubauer,Andreas Burchert
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes
Laurence Lamant,Aurélien de Reyniès,Marie-Michèle Duplantier,David S. Rickman,Frédérique Sabourdy,Sylvie Giuriato,Laurence Brugières,Philippe Gaulard,Estelle Espinos,Georges Delsol
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling
Sang-Hoon Sin,Debasmita Roy,Ling Wang,Michelle R. Staudt,Farnaz D. Fakhari,Dhavalkumar D. Patel,David Henry,William J. Harrington, Jr,Blossom A. Damania,Dirk P. Dittmer
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
K1 protein of human herpesvirus 8 suppresses lymphoma cell Fas-mediated apoptosis
Suizhao Wang,Shu Wang,Hoyoung Maeng,Daniel P. Young,Om Prakash,Luis E. Fayad,Anas Younes,Felipe Samaniego
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T-cell lymphoma: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials
Clinical Trials & Observations
Céline Bossard,Karim Belhadj,Felix Reyes,Nadine Martin-Garcia,Françoise Berger,Jean Alain Kummer,Josette Brière,Anne-Catherine Baglin,Stéphane Cheze,Jacques Bosq,Vincent Ribrag,Christian Gisselbrecht,Nicolas Mounier,Philippe Gaulard
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Expression of a non–DNA-binding isoform of Helios induces T-cell lymphoma in mice
Zheng Zhang,C. Scott Swindle,John T. Bates,Rose Ko,Claudiu V. Cotta,Christopher A. Klug
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia
Clinical Trials & Observations Brief Report
Ola Landgren,Joshua S. Rapkin,Neil E. Caporaso,Lene Mellemkjaer,Gloria Gridley,Lynn R. Goldin,Eric A. Engels
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Novel activating JAK2 mutation in a patient with Down syndrome and B-cell precursor acute lymphoblastic leukemia
Clinical Trials & Observations Brief Report
Sebastien Malinge,Raouf Ben-Abdelali,Catherine Settegrana,Isabelle Radford-Weiss,Marianne Debre,Kheira Beldjord,Elizabeth A. Macintyre,Jean-Luc Villeval,William Vainchenker,Roland Berger,Olivier A. Bernard,Eric Delabesse,Virginie Penard-Lacronique
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data

RED CELLS

Evidence for the multimeric structure of ferroportin
Ivana De Domenico,Diane McVey Ward,Giovanni Musci,Jerry Kaplan
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Transcriptional interference among the murine β-like globin genes
Xiao Hu,Susan Eszterhas,Nicolas Pallazzi,Eric E. Bouhassira,Jennifer Fields,Osamu Tanabe,Scott A. Gerber,Michael Bulger,James Douglas Engel,Mark Groudine,Steven Fiering
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Transport of the essential nutrient isoleucine in human erythrocytes infected with the malaria parasite Plasmodium falciparum
Rowena E. Martin,Kiaran Kirk
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

TRANSPLANTATION

Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease
Robert Zeiser,Vu H. Nguyen,Jing-Zhou Hou,Andreas Beilhack,Elizabeth Zambricki,Martin Buess,Christopher H. Contag,Robert S. Negrin
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
A GMCSF and IL-15 fusokine leads to paradoxical immunosuppression in vivo via asymmetrical JAK/STAT signaling through the IL-15 receptor complex
Moutih Rafei,Jian Hui Wu,Borhane Annabi,Laurence Lejeune,Moïra François,Jacques Galipeau
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Supplemental data
Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells
Clinical Trials & Observations
Abdulbaqi Al-toma,Otto J. Visser,Hyacintha M. van Roessel,B. Mary E. von Blomberg,Wieke H. M. Verbeek,Petra E. T. Scholten,Gert J. Ossenkoppele,Peter C. Huijgens,Chris J. J. Mulder
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Low-power laser in the prevention of induced oral mucositis in bone marrow transplantation patients: a randomized trial
Clinical Trials & Observations
Héliton Spíndola Antunes,Alexandre Mello de Azevedo,Luiz Fernando da Silva Bouzas,Carlos Alberto Esteves Adão,Claudia Tereza Pinheiro,Renato Mayhe,Lucia Helena Pinheiro,Renato Azevedo,Valkiria D'Aiuto de Matos,Pedro Carvalho Rodrigues,Isabele Avila Small,Renato Amaro Zangaro,Carlos Gil Ferreira
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia
Clinical Trials & Observations
John E. Wagner,Mary Eapen,Margaret L. MacMillan,Richard E. Harris,Ricardo Pasquini,Farid Boulad,Mei-Jie Zhang,Arleen D. Auerbach
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text

CORRESPONDENCE

Optimizing fusion transcript monitoring in CML
Mark Hertzberg,David McDonald
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Response: Reliability of PCR for BCR-ABL transcripts
Timothy Hughes,Susan Branford,John M. Goldman
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Improved outcome after stem-cell transplantation in FLT3/ITD-positive AML
Martin Bornhäuser,Thomas Illmer,Markus Schaich,Silke Soucek,Gerhard Ehninger,Christian Thiede,for the AML SHG 96 study group
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Response: Still a need for more robust evidence that FLT3/ITD status should influence the decision to proceed to transplantation in AML patients
Rosemary E. Gale,Robert Hills,Keith Wheatley,Alan K. Burnett,David C. Linch
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Metoclopramide treatment in DBA patients: no complete response in a French prospective study
Thierry M. Leblanc,Lydie Da Costa,Isabelle Marie,Pierre Demolis,Gilbert Tchernia
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Correction of the bleeding time in von Willebrand factor (VWF)–deficient mice using murine VWF
Peter J. Lenting,Philip G. de Groot,Simon F. De Meyer,Karen Vanhoorelbeke,Cynthia Pruss,David Lillicrap,Isabelle Marx,Cécile V. Denis
View Articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
All Issues

Advertisement intended for health care professionals

A phase 2 randomized study of modakafusp alfa as a single agent in patients with relapsed/refractory multiple myeloma
Clinical phenotype and pathophysiological mechanisms underlying qualitative Low VWF
Recycling is “bad to the bone” in patients with myeloma
A new variable to study in transplant: APOE variant status
Seeing is believing: a histology textbook’s dream case of sarcoidosis

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2025 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals